ALEXANDRIA, Va., Nov. 3 -- United States Patent no. 12,779,048, issued on Nov. 3, was assigned to Mayo Foundation for Medical Education and Research (Rochester, Minn.).
"Antibody-nanoparticle complexes and methods for making and using the same" was invented by Wendy K. Nevala (Oronoco, Minn.), Svetomir N. Markovic (Rochester, Minn.) and Liyi Geng (Rochester, Minn.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are nanoparticles complexed with binding agents and/or therapeutic agents (e.g., antibody-complexed albumin-bound paclitaxel/doxorubicin nanoparticles and antibody-complexed albumin-bound paclitaxel/SN38 nanoparticles) and pharmaceutical compositions thereof. Additionally, provided here...